Stocks and Investing
Stocks and Investing
Wed, August 12, 2015
[ 12:00 AM ] - United States, WOPRAI
Tue, August 11, 2015
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, August 10, 2015
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Matt Miksic Initiated (ABT) at Buy with Increased Target to $55 on, Aug 10th, 2015
Matt Miksic of Credit Suisse, Initiated "Abbott Laboratories" (ABT) at Buy with Increased Target from $50 to $55 on, Aug 10th, 2015.
Matt has made no other calls on ABT in the last 4 months.
There are 2 other peers that have a rating on ABT. Out of the 2 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matt
- Joanne Wuensch of "BMO Capital" Maintained at Buy with Increased Target to $56 on, Thursday, July 23rd, 2015
- Vijay Kumar of "Evercore ISI Group" Initiated at Strong Buy and Held Target at $54 on, Wednesday, May 27th, 2015
Contributing Sources